McKesson 2012 Annual Report Download - page 7

McKESSON CORPORATION
3
PART I
Item 1. Business.
General
McKesson Corporation (“McKesson,” the “Company,” the “Registrant” or “we” and other similar pronouns), is
a Fortune 15 corporation that delivers pharmaceuticals, medical supplies and health care information technologies
that make health care safer while reducing costs.
The Company’s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references in
this document to a particular year shall mean the Company’s fiscal year.
Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and
amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of
1934, as amended (the “Exchange Act,”) are available free of charge on our website (www.mckesson.com under the
“Investors – Financial Information – SEC Filings” caption) as soon as reasonably practicable after we electronically
file such material with, or furnish it to, the Securities and Exchange Commission (“SEC” or the “Commission”).
The content on any website referred to in this Annual Report on Form 10-K is not incorporated by reference into this
report, unless expressly noted otherwise.
The public may also read or copy any materials that we file with the SEC at the SEC’s Public Reference Room
at 100 F Street, NE, Washington, D.C. 20549. The public may obtain information on the operation of the Public
Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains a website that contains reports, proxy
and information statements, and other information regarding issuers, including the Company, that file electronically
with the SEC. The address of the website is http://www.sec.gov.
Business Segments
We operate in two segments. The McKesson Distribution Solutions segment distributes ethical and proprietary
drugs, medical-surgical supplies and equipment and health and beauty care products throughout North America.
This segment also provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers, and
practice management, technology, clinical support and business solutions to oncology and other specialty practices
operating in the community setting. In addition, this segment sells financial, operational and clinical solutions for
pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing and other services. This segment
includes a 49% interest in Nadro, S.A. de C.V. (“Nadro”), one of the leading pharmaceutical distributors in Mexico.
The McKesson Technology Solutions segment delivers enterprise-wide clinical, patient care, financial, supply
chain, strategic management software solutions, pharmacy automation for hospitals, as well as connectivity,
outsourcing and other services, including remote hosting and managed services, to healthcare organizations. This
segment also includes our Payer group of businesses, which includes our InterQual® clinical criteria solution,
medical management tools, claims payment solutions, network performance tools and care management programs.
This segment’s customers include hospitals, physicians, homecare providers, retail pharmacies and payers from
North America, the United Kingdom, Ireland, other European countries and Israel.
Net revenues for our segments for the last three years were as follows:
(Dollars in billions) 2012 2011 2010
Distribution Solutions $ 119.4 97% $ 108.9 97% $ 105.6 97%
Technology Solutions 3.3 3% 3.2 3% 3.1 3%
Total $ 122.7 100% $ 112.1 100% $ 108.7 100%